Cardiovascular risk in Type 2 Diabetes

Cardiovascular problems are related with a higher incidence of type 2 diabetes. The syndrome frequently coexists with a number of risk factors that advance atherosclerosis and cardiovascular disease, including obesity, hypertension, dyslipidaemia, and insulin resistance. Changes in lifestyle, glycaemic control, blood pressure management, lipid management, and antiplatelet therapy are all part of managing cardiovascular risk in type 2 diabetes. To lessen the burden of cardiovascular disease in patients with type 2 diabetes, a thorough cardiovascular risk assessment and individualised treatment plans are necessary.

    Related Conference of Cardiovascular risk in Type 2 Diabetes

    November 20-21, 2025

    21st World Congress on Endocrinology & Diabetes

    Paris, France
    November 24-25, 2025

    6th International conference on Diabetic complications

    Barcelona, Spain
    February 09-10, 2026

    20th International Conference on Endocrinology, Diabetes and Metabolism

    Singapore City, Singapore
    February 12-13, 2026

    5th Global Summit on Physiology and Metabolism of Thyroid

    Singapore City, Singapore
    February 23-24, 2026

    19th International Summit on Diabetes

    London, UK
    February 25-26, 2026

    16th World Congress on Endocrinology and Diabetes

    Paris, France
    March 26-27, 2026

    7th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands
    May 14-15, 2026

    7th World Summit on Diabetes

    Rome, Italy
    May 18-19, 2026

    57th Annual Congress on Endocrinology and Diabetes Research

    Aix-en-Provence, France

    Cardiovascular risk in Type 2 Diabetes Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in